Nasal spray sedation showdown: which drug works best for kids and adults?

NCT ID NCT07166666

Not yet recruiting Symptom relief Sponsor: Oman Medical Speciality Board Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests two different drug combinations given as a nasal spray to help patients relax during medical procedures. It includes 128 people aged 2 to 60 years old. The goal is to see which approach provides better sedation, faster recovery, and fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Midazolam, fentanyl, and dexmedetomidine (given via nasal spray atomizer)
What this could lead to: If it works, this could show that atomized sedation is a safe and effective option for both children and adults during medical procedures.
What could go wrong: This is a small, early-stage trial (128 participants) comparing different drugs, so results may not apply to all patients or settings. Side effects like breathing problems or allergic reactions are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANALGESIA ASSESSMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANALGESIA ASSESSMENT SEDATION

Contacts and locations

Locations

dr.Suad al baluish

Muscat, Oman

More trials for these conditions

Other studies related to the condition(s) this trial covers.